AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Emsita M 100mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Emcure Pharmaceuticals Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Emsita M 100mg/500mg Tablet SR

Diabexe Duo 100mg/500mg Extended-Release Tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabexe Duo may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood sugar readings, and current medications. Consuming it with meals minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Adherence to your physician's dietary and exercise plan is crucial for diabetes control, as lifestyle significantly impacts management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; learn to recognize and manage this condition. This medication isn't suitable for all patients. Inform your doctor of any pre-existing kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or lactating women require medical consultation prior to use. Interactions with other drugs are possible; disclose all medications to your physician to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout your treatment.

Uses of Emsita M 100mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Emsita M 100mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the Emsita M 100mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Emsita M 100mg/500mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Emsita M 100mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Emsita M 100mg/500mg Tablet SR whole; do not chew, crush, or divide it. Administer this medication with a meal.

How Emsita M 100mg/500mg Tablet SR works:

Emsita M 100mg/500mg Extended-Release Tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin secretion from the pancreas, improves insulin utilization, and diminishes hepatic glucose production. Metformin, a biguanide, reduces liver glucose output, slows intestinal glucose absorption, and increases insulin sensitivity. This dual-action combination results in improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Emsita M 100mg/500mg SR tablets with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Emsita M 100mg/500mg tablet may pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Emsita M 100mg/500mg tablets are likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose levels are either elevated or depressed. Refrain from driving should these conditions arise.

KidneyKidneyCAUTION

The extended-release Emsita M 100mg/500mg tablet requires careful administration in individuals with impaired kidney function. Dosage modification of Emsita M 100mg/500mg may be necessary; physician consultation is recommended. Prescribing Emsita M 100mg/500mg is contraindicated for patients exhibiting severe renal insufficiency. Routine monitoring of kidney function is advised during treatment.

LiverLiverUNSAFE

The extended-release Emsita M 100mg/500mg tablet is contraindicated in individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Emsita M 100mg/500mg Tablet SR :

Should you forget to take your Emsita M 100mg/500mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Emsita M 100mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Emsita M 100mg/500mg Tablet SR

Emsita M 100mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Emsita M 100mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Emsita M 100mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Emsita M 100mg/500mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Emsita M 100mg/500mg Tablet SR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Emsita M 100mg/500mg SR tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Emsita M 100mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Emsita M 100mg/500mg Tablet SR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Emsita M 100mg/500mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Emsita M 100mg/500mg Tablet SR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Emsita M 100mg/500mg Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is a reason to avoid this medication in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Emsita M 100mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Emsita M 100mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Emsita M 100mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Emsita M 100mg/500mg Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Emsita M 100mg/500mg Tablet SR and alcohol is unsafe and may heighten the risk of lactic acidosis.
Emsita M 100mg/500mg Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding its use in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Emsita M 100mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Emsita M 100mg/500mg Tabl...
160
MRP 186
13% off